COVIPLID - Use of high titer anti-SARS-CoV-2 convalescent plasma in immunocompromised patients with COVID-19: a prospective national cohort
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ANRS0408
Grant search
Key facts
Disease
COVID-19Start & end year
2022Known Financial Commitments (USD)
$519,345.7Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Principal Investigator
LACOMBE KarineResearch Location
FranceLead Research Institution
Sorbonne Université (UMRS1136)Research Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
N/A